• PRODUCT AVAILABILITY: Did you know you can view a product's availability right on the product page? Simply enter the quantity you want to purchase and the current availability will appear below the item.

  • This product requires a special fee, which will be shown on the Review page during Checkout.

MilliporeSigma

Tideglusib =98% (HPLC)

100 out of 100

NOTE: Due to special handling or shipping requirements, these products will have additional fees added during checkout. Click HERE for a description of what fees might be charged.

Synonym: 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione, NP-12, NP031112

CAS Number: 865854-05-3

Empirical Formula (Hill Notation): C19H14N2O2S

Molecular Weight: 334.39

MDL Number: MFCD18633296

Biochem/physiol Actions
Tideglusib, also known as NP031112 or NP-12, is a potent non ATP-competitive inhibitor of glycogen synthase kinase-3 (GSK3), an important kinase studied in stem cell research and neurodegenerative diseases. It is currently in clinical trials for Alzheimer′s disease and Progressive Supranuclear Palsy (PSP). Tideglusib reduces phosphorylation of the tau protein and the accumulation of amyloid plaques, reduces hippocampal and entorhinal cortex neuron loss and improves spatial memory deficits. It has also shown neuroprotective and anti-inflammatory activity in a variety of animal models.

Assay: ≥98% (HPLC)

Form: powder

Color: white to beige

Solubility: DMSO: >15 mg/mL

Storage Temp.: 2-8°C

Please Enter Your Order Info

Filter by:

  • Clear Filters
Product Detail
Thomas No.
C974Y23
Mfr. No.
SML0339-10MG
Description
Tideglusib, 10 mg
list price/quantitytotal
$0.00
Thomas No.
C974Y24
Mfr. No.
SML0339-50MG
Description
Tideglusib, 50 mg
list price/quantitytotal
$0.00
$0.00 (0 Items)
Product is restricted and can only be purchased by customers with a web profile linked to a Thomas Business Account - Click here to login or create your web profile.

To write a review you must log in

  • Reviewed on Saturday, August 25, 2018

    100 out of 100

    Comments
    Great
  • Reviewed on Sunday, November 19, 2017

    100 out of 100

    Comments
    Excellent trial.
  • Reviewed on Tuesday, January 10, 2017

    100 out of 100

    Comments
    very nice